Evaluation of stabilized whole blood control materials for lymphocyte immunophenotyping. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Evaluation of stabilized whole blood control materials for lymphocyte immunophenotyping.

Cytometry. 1999 Dec 15;38(6):268-73. Unique Identifier : AIDSLINE MED/20057744
Nicholson JK; Hubbard M; Dawson CD; HIV Immunology and Diagnostics Branch, Division of AIDS, STD, and; TB Laboratory Research, National Center for Infectious Diseases,; Centers for Disease Control and Prevention, Atlanta, Georgia; 30333, USA. jkn1@cdc.gov


Abstract: We evaluated stabilized whole blood control materials for their performance as a routine control material for immunophenotyping using flow cytometry. These materials serve as the method control, controlling for both the binding of monoclonal antibodies to the cells and the efficiency of the red-blood-cell lysing reagent. Three products (FluoroTrol, StatusFlow, and CD-Chex): were tested. The controls performed very well in evaluating both CD4 and CD8 percentages and absolute cell counts using flow cytometry. Light scattering patterns and fluorescence intensity of antibody binding were slightly different from those of normal whole blood. These products are not appropriate for quantitative fluorescence standards. Cytometry (Comm. Clin. Cytometry) 38:268-273, 1999. Published 1999 Wiley-Liss, Inc.


Keywords: JOURNAL ARTICLE Blood Chemical Analysis/*METHODS Blood Physiology CD4-Positive T-Lymphocytes/CYTOLOGY CD8-Positive T-Lymphocytes/CYTOLOGY Evaluation Studies Flow Cytometry Human Immunophenotyping/*METHODS Quality Control

KWDjournalarticlebloodchemicalanalysis/KWDmethodsbloodphysiologycd4-positivet-lymphocytes/cytologycd8-positivet-lymphocytes/cytologyevaluationstudiesflowcytometryhumanimmunophenotyping/KWDmethodsqualitycontrol
000430
A0040369


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .